Global Eubiotics Market By Product Overview
Introduction:
Eubiotics are animal feed additives which increase nutritional value of that feed. Primary purpose of eubiotics is to provide an improved health status and performance to the animals. Eubiotics helps in proper absorption of nutrients. It is beneficial to host animal as well as in the animal production. It provides digestive enzymes as well as additional source of nutrients. Eubiotics are made up of natural plant extracts and carboxylic acids. Eubiotics are referred as healthy balance of the micro biota in the gastrointestinal tract. Eubiotics term refers to the upkeep of micro flora within the intestinal tract. Eubiotics are mainly wont to improve the health status also as performance improvement in domesticated animals. They mostly include probiotics, prebiotics, organic acids and essential oils. The efficacy of the merchandise is especially hooked in to the antimicrobial effects also as their ability to change the gut flora. Eubiotics are gaining importance in developed countries with an increasing number of nations are limiting the utilization of antibiotics. Eubiotics helps in improving the system and thus plays a significant role within the system. Eubiotics are the natural digestive stimulants, which create healthy balance of micro flora within the alimentary canal. For the activation of the immune reaction against diseases the inclusion of dietary organic acids features a eubiotic effect on the proliferation of indigenous carboxylic acid bacteria. It refers to feed additives like prebiotics, probiotics, and organic acids. Eubiotics are good for digestive health and act as a substitute to antibiotics in feed. Eubiotics Market accounted for US$ 4.8 billion in 2020 and is estimated to be US$ 9.8 billion by 2030 and is anticipated to register a CAGR of 7.5%.
Global Eubiotics Market By Product Dynamics
Increasing awareness regarding meat quality
Increasing awareness regarding meat quality, coupled with the rising demand for animal protein products across the globe are major factors driving growth of the eubiotics market. In addition, ban on use of antibiotics in some countries boost the demand for its alternatives such as eubiotic which is another factor propelling growth of the target market.
Furthermore, adverse health effect on animals due to use of antibiotics is supporting growth of the target market. Moreover, adverse health effect on animals due to use of antibiotics is supporting growth of the target market. However, increasing complexities in food production chain and trade complexities due to imposition of stringent regulations by regulatory bodies across the globe are expected to restrain growth of the eubiotics market.
Global Eubiotics Market By Product Segmentation
The eubiotics market has been segmented on the basis of product, dosage form, application, livestock, and region.
On the basis of product the eubiotics market is segmented into probiotics, prebiotics, organic acids, and essential oils. The probiotics product segment is expected to dominate in the target market over the forecast period. Based on dosage form the target market is segmented into dry and liquid dosage form. On the basis of application the eubiotics market is bifurcated into gut health, immunity, yield, and others. Others sub-segment includes productivity and nutrition. The gut health application segment is expected to be the largest segment in the eubiotics market in the near future. On the basis of livestock the target market is segmented into poultry, swine, aquatic, and ruminants. The poultry livestock segment is anticipated to dominate the eubiotics market over the forecast period.
Regional Insights
On the basis of region the eubiotics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Europe is expected to account for major market share as compared to that of other regions in the near future, owing to strict ban on usage of antibiotics as a growth promoter in this region. Asia Pacific is expected to account for a second-highest market share in terms of revenue over the forecast period. This is due to strong demand for eubiotics from countries such as China and India in the region.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Product- Probiotics, Prebiotics, Organic Acids, And Essential Oils By Dosage Form- Dry and Liquid By Application- Gut Health, Immunity, Yield, And Others. By Livestock- Poultry, Swine, Aquatic, And Ruminants |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Erectile Dysfunction Market, By Region:
- North America
- North America Erectile Dysfunction Market, By Product
- North America Erectile Dysfunction Market, By Dosage Form
- North America Erectile Dysfunction Market, By Application
- North America Erectile Dysfunction Market, By Livestock
- North America Erectile Dysfunction Market, By Country
- U.S.
- Canada
- Europe
- Europe Erectile Dysfunction Market, By Product
- Europe America Erectile Dysfunction Market, By Dosage Form
- Europe Erectile Dysfunction Market, By Application
- Europe Erectile Dysfunction Market, By Livestock
- Europe Erectile Dysfunction Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Switzerland
- Sweden
- Rest of Europe
- Asia-Pacific
- Asia-Pacific Erectile Dysfunction Market, By Product
- Asia-Pacific Erectile Dysfunction Market, By Dosage Form
- Asia-Pacific Erectile Dysfunction Market, By Application
- Asia-Pacific Erectile Dysfunction Market, By Livestock
- Asia-Pacific Erectile Dysfunction Market, By Country
- China
- India
- Australia & New Zealand
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Erectile Dysfunction Market, By Product
- Latin America Erectile Dysfunction Market, By Dosage Form
- Latin America Erectile Dysfunction Market, By Application
- Latin America Erectile Dysfunction Market, By Livestock
- Latin America Erectile Dysfunction Market, By Country
- Brazil
- Mexico
- Argentina and Chile
- Rest of Latin America
- Middle East
- Middle East Erectile Dysfunction Market, By Product
- Middle East Erectile Dysfunction Market, By Dosage Form
- Middle East Erectile Dysfunction Market, By Application
- Middle East Erectile Dysfunction Market, By Livestock
- Middle East Erectile Dysfunction Market, By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- Africa Erectile Dysfunction Market, By Product
- Africa Erectile Dysfunction Market, By Dosage Form
- Africa Erectile Dysfunction Market, By Application
- Africa Erectile Dysfunction Market, By Livestock
- Africa Erectile Dysfunction Market, By Country
- North Africa
- Central Africa
- South Africa
Global Eubiotics Market By Product Key Players
Key players operating in the eubiotics market includes Cargill INC, BASF SE, E. I. du Pont de Nemours and Company, Koninklijke DSM N. V., Chr. Hansen Holding A/S, Novozymes A/S, Calpis Co., Ltd., Lesaffre et Compagnie, SA, Kemin Industries, Inc., and Lallemand Inc.
Global Eubiotics Market By Product Company Profile
- Cargill Inc
- Business Strategies Overview
- Financial Performance
- Key Highlights
- Product Portfolio
- Company Overview
- BASF SE
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- E.I. du Pont de Nemours and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Koninklijke DSM N.V.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Chr. Hansen Holding A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Novozymes A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Calpis Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Lesaffre et Compagnie
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Kemin Industries Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Lallemand Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
Global Eubiotics Market By Product Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Eubiotics Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product
- Market Snippet, By Dosage Form
- Market Snippet, By Application
- Market Snippet, By Livestock
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Probiotics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Prebiotics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Organic Acids
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Essential Oils
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Dosage Form, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Dry
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Liquid
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Application, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Gut Health
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Immunity
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Yield
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Livestock, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Poultry
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Swine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Aquatics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Ruminants
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Dosage Form, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Livestock, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Dosage Form, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Livestock, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Dosage Form, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Livestock, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Dosage Form, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Livestock, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Dosage Form, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Livestock, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Cargill Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- BASF SE
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- E.I. du Pont de Nemours and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Koninklijke DSM N.V.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Chr. Hansen Holding A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Novozymes A/S
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Calpis Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Lesaffre et Compagnie
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Kemin Industries Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Lallemand Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies Overview
- Cargill Inc
The Last Word
- Future Impact
- About Us
- Contact
FAQs
eubiotics market has been segmented on the basis of product, dosage form, application, livestock, and region.
Increasing awareness regarding meat quality, coupled with the rising demand for animal protein products across the globe are major factors driving growth of the eubiotics market.
Europe is expected to account for major market share as compared to that of other regions in the near future, owing to strict ban on usage of antibiotics as a growth promoter in this region.
Key players operating in the eubiotics market includes Cargill INC, BASF SE, E. I. du Pont de Nemours and Company, Koninklijke DSM N. V., Chr. Hansen Holding A/S, Novozymes A/S, Calpis Co., Ltd., Lesaffre et Compagnie, SA, Kemin Industries, Inc., and Lallemand Inc.